Individuals with obesity are more likely to develop atrial fibrillation (AFib), according to a study published April 18 in the American Journal of Cardiology.

The FDA has approved a firmware update aimed at addressing two previously reported issues with some of Abbott’s implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).

A regular intake of up to 300 mg of coffee a day appears to be safe and may even be protective against heart rhythm disorders, including atrial fibrillation (AFib), according to a new review published April 16 in the Journal of the American College of Cardiology.

Only half of medical advice on an online message board dedicated to implanted cardiac defibrillators (ICDs) appears to be accurate, according to preliminary research presented April 7 at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions 2018.

Atrial fibrillation (AFib) ablation techniques used on individuals without cardiac abnormalities can be safely applied to adults with congenital heart disease (CHD), according to a new study in JACC: Clinical Electrophysiology. But in many cases, multiple ablation procedures are needed to boost the chances of arrhythmia-free survival.

A 6-month-old German Shepherd was the beneficiary of a successful cardiac ablation at Cornell University Hospital for Animals, one of only two centers in the U.S. that regularly offers the procedure for dogs.

Patients who developed new-onset postoperative atrial fibrillation (POAF) after coronary artery bypass graft (CABG) surgery showed a 33 percent reduced risk of thromboembolism long-term when compared to those with nonsurgical AFib, according to a study published March 28 in JAMA Cardiology.

Santa Monica, CA, March 28, 2018 — BioSig Technologies, Inc. (OTCQB: BSGM) announced that the Company has filed 510(k) application to the U.S. Food and Drug Administration (FDA) for its first product, PURE EP(TM) System.